Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ibrahim, Karadag"'
Autor:
Seda Kahraman, Serdar Karakaya, Muhammed Ali Kaplan, Sema Sezgin Goksu, Akin Ozturk, Zehra Sucuoglu Isleyen, Jamshid Hamdard, Sedat Yildirim, Tolga Dogan, Selver Isik, Abdussamet Celebi, Burcu Belen Gulbagci, Nail Paksoy, Mutlu Dogan, Haci Mehmet Turk, Ahmet Bilici, Ali Murat Tatli, Sinem Akbas, Nedim Turan, Ilhan Hacibekiroglu, Gamze Gokoz Dogu, Adnan Aydiner, Ahmet Taner Sumbul, Serap Akyurek, Merih Yalciner, Ahmet Demirkazik, Pinar Gursoy, Musa Baris Aykan, Elif Sahin, İbrahim Karadag, Osman Kostek, Muhammed Muhiddin Er, Mehmet Artaç, Yakup Duzkopru, Dincer Aydin, Deniz Isik, Yusuf Karakas, Saadettin Kilickap, Cihan Erol, Bilgin Demir, Burak Civelek, Yakup Ergun, Muhammed Bulent Akinci, Izzet Dogan, Nuri Karadurmus, Perran Fulden Yumuk, Mehmet Ali Nahit Sendur
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Central nervous system (CNS) metastases can be seen at a rate of 30% in advanced stages for patients with non-small cell lung cancer (NSCLC). Growing evidence indicates the predictive roles of driver gene mutations in the development of brai
Externí odkaz:
https://doaj.org/article/dfd4fc84465f4b4985707fa241e217b7
Autor:
Ahmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, Berna Oksuzoglu, Ahmet Sezer, Nuri Karadurmus, Erdem Cubukcu, Mehmet Ali Nahit Sendur, Sercan Aksoy, Dilek Erdem, Gul Basaran, Burcu Cakar, Abdallah T. M. Shbair, Cagatay Arslan, Ahmet Taner Sumbul, Sema Sezgin Goksu, Ibrahim Karadag, Irfan Cicin, Mahmut Gumus, Fatih Selcukbiricik, Hakan Harputluoglu, Umut Demirci
Publikováno v:
Acta Oncologica. 62:381-390
Autor:
Ibrahim Karadag, Serdar Karakaya, Tolga Akkan, Bilgin Demir, Ertugrul Gazi Alkurt, Mutlu Dogan
Publikováno v:
Cancer Management and Research. 15:311-317
Ibrahim Karadag,1 Serdar Karakaya,2 Tolga Akkan,3 Bilgin Demir,4 Ertugrul Gazi Alkurt,5 Mutlu Dogan6 1Department of Medical Oncology, Hitit University Erol Olcok Training and Research Hospital, Corum, Turkey; 2Department of Medical Oncology, Health S
Autor:
Nuriye Ozdemir, Irem Bilgetekin, Esra Zeynelgil, Mustafa Altinbaş, Ismail Erturk, Selin Akturk Esen, Dogan Uncu, Musa Baris Aykan, Goksen Inanc Imamoglu, Yeşim Yıldız, Cengiz Karacin, Ahmet Ozet, Burak Civelek, Ismail Celik, Gokhan Ucar, Fatma Buğdaycı Başal, Nuri Karadurmus, Ozan Yazıcı, Bedia Dinc, Ibrahim Karadag, Omur Berna Oksuzoglu, Osman Sütcüoğlu, Yakup Ergun, Mutlu Dogan, Tulay Eren
Publikováno v:
Future Oncology
Aim: To evaluate the immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy. Methods: This multicenter, prospective, observational study was conducted with 47 patients receiving active systemic th
Publikováno v:
Journal of the College of Physicians and Surgeons Pakistan. 31:326-329
Objective To compare the chemoradiotherapy for esophageal cancer followed by surgery study (CROSS) and continuous infusion 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) protocols administered in distal esophageal and gastroesophageal junction (
Autor:
Farhad Farzaliyev, Alexander Touma, Hans-Ulrich Steinau, Rainer Hamacher, Halil-Ibrahim Karadag, Lars Erik Podleska
Publikováno v:
Orthoplastic Surgery, Vol 1, Iss, Pp 3-10 (2020)
Introduction The treatment of soft tissue and bone sarcoma of the hand and wrist are based on general principles rather than on specific data due to the rare incidence of cases. The current study was conducted to analyze the survival and functional o
Publikováno v:
Materials Testing. 62:957-961
This paper presents the effect of cutting tool, cutting speed and feed rate on the flank wear and surface roughness of austenitic stainless steel (AISI 304) during wet turning. Turning tests were designed based on the Taguchi method (L18). An orthogo
Publikováno v:
Indian Journal of Cancer.
Autor:
Ozturk, Ates, O Berna, Oksuzoglu, Burak Yasin, Aktas, Ibrahim, Karadag, Selin, Esen, Serdar, Karakaya, Dogan, Uncu, Cihan, Erol, Mustafa, Gurbuz, Bulent, Yalcin, Sercan, Aksoy
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(4)
Recently, neoadjuvant treatment approach has gained importance in locally advanced HER-2 positive breast cancer. Adding pertuzumab increases pathological complete response (pCR). In this study, we aimed to examine the clinicopathologic features that
Autor:
Serdar, Karakaya, Ibrahim, Karadag, Cigdem, Ozdilekcan, Esra, Durmusoglu, Ozturk, Ates, Omur Berna, Cakmak Oksuzoglu
Publikováno v:
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 32(3)
To investigate whether the use of diffusing capacity of the lungs for carbon monoxide (DLCO) and neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) could be used to predict bleomycin-induced pulmonary toxicity in patients with t